Anne-Christine Thierry Center of Experimental Therapeutics, Department of Oncology Centre Hospitalier Universitaire Vaudois Biography Publications Institution JoVE Articles Anne-Christine Thierry has not added a biography. If you are Anne-Christine Thierry and would like to personalize this page please email our Author Liaison for assistance. Publications A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients Frontiers in Immunology. 2019 | Pubmed ID: 31440238 50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial International Journal of Radiation Oncology, Biology, Physics. 02, 2019 | Pubmed ID: 30267761 The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 01, 2019 | Pubmed ID: 29945169 Safety of Human Immunisation with a Live-attenuated Mycobacterium Tuberculosis Vaccine: a Randomised, Double-blind, Controlled Phase I Trial The Lancet. Respiratory Medicine. Dec, 2015 | Pubmed ID: 26598141 Safety and Immunogenicity of the M72/AS01 Candidate Tuberculosis Vaccine in HIV-infected Adults on Combination Antiretroviral Therapy: a Phase I/II, Randomized Trial AIDS (London, England). Jul, 2014 | Pubmed ID: 24911353 Safety and Immunogenicity of Immunotherapy with Bet V 1-derived Contiguous Overlapping Peptides The Journal of Allergy and Clinical Immunology. Jul, 2014 | Pubmed ID: 24797422 Novel Birch Pollen Specific Immunotherapy Formulation Based on Contiguous Overlapping Peptides Clinical and Translational Allergy. Jun, 2013 | Pubmed ID: 23725004 Intragastric and Intranasal Administration of Lactobacillus Paracasei NCC2461 Modulates Allergic Airway Inflammation in Mice International Journal of Inflammation. 2012 | Pubmed ID: 22762009 Meting van het mitochondriale massa-en membraanpotentiaal in hematopoietische stamcellen en T-cellen doorstroming Cytometrie Mukul Girotra*1,2, Anne-Christine Thierry3, Alexandre Harari1,3, George Coukos1, Olaia Naveiras2,4, Nicola Vannini*1 1Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 2Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 3Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, 4Hematology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) JoVE 60475 Biology
Meting van het mitochondriale massa-en membraanpotentiaal in hematopoietische stamcellen en T-cellen doorstroming Cytometrie Mukul Girotra*1,2, Anne-Christine Thierry3, Alexandre Harari1,3, George Coukos1, Olaia Naveiras2,4, Nicola Vannini*1 1Department of Oncology UNIL CHUV, Ludwig Institute for Cancer Research Lausanne, University of Lausanne, 2Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), 3Center of Experimental Therapeutics, Department of Oncology, Centre Hospitalier Universitaire Vaudois, 4Hematology Service, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) JoVE 60475 Biology